Francisco Cebollero, MD
Gastroenterology · Mayaguez, PRNPI 1073674271
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,385 of the $52,105 with a category attached, or 89.0%. AbbVie accounts for 97.0% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $14,452, 2.8 times the $5,237 reported in 2019. Among gastroenterology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $457.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$51K
- E.r. Squibb & Sons, L.L.C.$633
- Janssen Scientific Affairs, LLC$291
- Gilead$231
- Madrigal Pharmaceuticals$144
- Merck$98
- plus $173 from 4 others
What the payments were for
- Consulting fees$2,1004%
- Speaking & faculty fees$46,38589%
- Travel & lodging$750%
- Food & beverage$3,5467%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $50,536 |
| E.r. Squibb & Sons, L.L.C. | 8 | $633 |
| Janssen Scientific Affairs, LLC | 3 | $291 |
| Gilead | 4 | $231 |
| Madrigal Pharmaceuticals | 1 | $144 |
| Merck | 1 | $98 |
| Pfizer Pharmaceuticals LLC | 2 | $97 |
| Novo Nordisk | 1 | $32 |
| PBG Puerto Rico LLC | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,105 in reported general payments places this provider in the 95th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 39 | $126,571 |
| Everolimus | 11 | $22,210 |
| Tacrolimus | 339 | $18,228 |
| Mesalamine | 27 | $14,824 |
| Entecavir | 60 | $13,853 |
| Mycophenolate Mofetil | 134 | $9,421 |
| PrografTacrolimus | 16 | $8,791 |
| EliquisApixaban | 12 | $8,319 |
| Sirolimus | 37 | $4,188 |
| Cyclosporine ModifiedCyclosporine, Modified | 21 | $3,499 |
| Ursodiol | 40 | $3,245 |
| Lactulose | 43 | $2,959 |
| Omeprazole | 556 | $2,941 |
| Cholestyramine LightCholestyramine | 55 | $2,526 |
| Propranolol Hcl | 142 | $2,512 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Mayaguez
- Carlos MicamesMayaguez$22K
- Omar Perez JimenezMayaguez$16K
- Priscilla Medero RodriguezMayaguez$7K
- Edward SinghMayaguez$6K
- Yue Jao AyalaMayaguez$6K
- Viviana Caban GarcesMayaguez$4K
- Felix Rivera BorgesMayaguez$3K
- Ahmed Morales JorgeCoto Laurel$214K
- Barbara Rosado CarrionPonce$176K
- Rafael Pastrana LabordeHato Rey$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.